Does Rallies track congressional trades in ATR?

Yes. Rallies tracks politician and congressional stock disclosures for ATR, including reported purchases, sales, dates, owners, and trade amounts when available.

Is ATR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATR. It does not provide personalized investment advice.

ATR (AptarGroup, Inc.) Stock Analysis - Politician Trades

AptarGroup, Inc. (ATR) is a publicly traded Healthcare sector company. As of May 21, 2026, ATR trades at $115.24 with a market cap of $7.39B and a P/E ratio of 19.45. ATR moved +1.27% today. Year to date, ATR is -6.29%; over the trailing twelve months it is -27.29%. Its 52-week range spans $103.23 to $178.03. Analyst consensus is buy with an average price target of $145.80. Rallies surfaces ATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ATR stock?

Recent politician trading activity in ATR includes disclosures from Michael McCaul, Michael McCaul, Michael McCaul, Lisa McClain, and Michael McCaul. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

ATR Key Metrics

Key financial metrics for ATR
Metric	Value
Price	$115.24
Market Cap	$7.39B
P/E Ratio	19.45
EPS	$5.91
Dividend Yield	0.48%
52-Week High	$178.03
52-Week Low	$103.23
Volume	204
Avg Volume	0
Revenue (TTM)	$3.87B
Net Income	$386.60M
Gross Margin	0.00%

Congressional Trades in ATR

Michael McCaul purchase ATR on Nov 19, 2025 (amount: $50.00K) for Spouse.
Michael McCaul purchase ATR on Sep 22, 2025 (amount: $50.00K) for Spouse.
Michael McCaul purchase ATR on Sep 11, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase ATR on Jun 24, 2025 (amount: $15.00K) for Spouse.
Michael McCaul sale ATR on Aug 26, 2024 (amount: $15.00K) for Spouse.

Latest ATR News

AptarGroup drops after Q1 profit and margins slide on pharma destocking — May 1, 2026
AptarGroup Q1 Sales Up 11% to $982.9M, Adjusted EPS $1.19 — Apr 30, 2026
AptarGroup drops as 2026 emergency-medicine destocking and margin pressure weigh — Apr 21, 2026
AptarGroup jumps as Wall Street upgrade lifts target to $144 — Apr 8, 2026
AptarGroup Q4 Sales Up 14% to $963M, Board Authorizes $600M Buyback — Feb 6, 2026

Recent ATR Insider Trades

Hudson Irene Elizabeth sold 422 (~$52.07K) on May 7, 2026.
Hudson Irene Elizabeth sold 842 (~$103.95K) on May 7, 2026.

ATR Analyst Consensus

5 analysts cover ATR: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.80.

Common questions about ATR

Which politicians traded ATR stock?: Recent politician trading activity in ATR includes disclosures from Michael McCaul, Michael McCaul, Michael McCaul, Lisa McClain, and Michael McCaul. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in ATR?: Yes. Rallies tracks politician and congressional stock disclosures for ATR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ATR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATR. It does not provide personalized investment advice.